• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Sage Therapeutics

Quote








Sage facts:

1. Hired the rah rah RBD and DBM “leaders” from Novo who got canned when Gilot got dumped.

2. Hired a bunch of reps knowing the new drug is delayed due to no therapeutic advantage but much higher cost/challenge in this market.

3. Will compete against generic Zoloft and other SSRIs which work effectively.

Novo is not the fun place it once was but I like it better here than there and did consider it for a minute.
 




anonymous said:
Sage facts:

1. Hired the rah rah RBD and DBM “leaders” from Novo who got canned when Gilot got dumped.

2. Hired a bunch of reps knowing the new drug is delayed due to no therapeutic advantage but much higher cost/challenge in this market.

3. Will compete against generic Zoloft and other SSRIs which work effectively.

Novo is not the fun place it once was but I like it better here than there and did consider it for a minute.
Click to expand...

Generic Zoloft is great for PPD and has a track record. Cheap too
 












anonymous said:
Generic Zoloft is pennies per dollar. It works and will be used before an expensive and unproven infusion. Insurance companies control the game.
Click to expand...

Dynamite insight, thanks for the hot take. Just because insurance companies are going to push for generic alternatives doesn’t mean they work, or are even all that effective. there are new ssri’s that continue coming to market. Just because there’s something that helps some doesn’t mean there isn’t room for innovation champ.
 




anonymous said:
I can't understand how I didn't get even a screening call from a recruiter. I might suck but not on paper.
Click to expand...


There are people that were hired that didn’t get a call from a recruiter. They were hand picked. And no, I’m not disgruntled. I was offered a position and decided after looking at the whole picture that Sage wasn’t for me. I got offered a great opportunity by another company that was a better fit and the manager saw my value. Now I’m making more money with the company I decided to go with, in a position that aligns with my experience and I look forward to the start date with my new company.
 




anonymous said:
Dynamite insight, thanks for the hot take. Just because insurance companies are going to push for generic alternatives doesn’t mean they work, or are even all that effective. there are new ssri’s that continue coming to market. Just because there’s something that helps some doesn’t mean there isn’t room for innovation champ.
Click to expand...

Champ, not really innovative for Sage unless innovation means mind boggling expensive. Um, Zoloft works per NIH. Good luck with insurance.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945214/
 
















anonymous said:
There are people that were hired that didn’t get a call from a recruiter. They were hand picked. And no, I’m not disgruntled. I was offered a position and decided after looking at the whole picture that Sage wasn’t for me. I got offered a great opportunity by another company that was a better fit and the manager saw my value. Now I’m making more money with the company I decided to go with, in a position that aligns with my experience and I look forward to the start date with my new company.
Click to expand...

Is anyone else painfully underwater on the 27 stock options this chincy company gave us at sign on?
 




















Top Bottom
Back
Quote